Clinical Evaluation of QFlu Combo Test (QFlu)
|ClinicalTrials.gov Identifier: NCT01506583|
Recruitment Status : Unknown
Verified January 2012 by Cellex, Inc..
Recruitment status was: Recruiting
First Posted : January 10, 2012
Last Update Posted : January 10, 2012
|Condition or disease|
|Cough Myalgia Nasal Obstruction Sore Throat Headache Fatigue Fever|
|Study Type :||Observational|
|Estimated Enrollment :||1000 participants|
|Official Title:||Clinical Evaluation of QFlu Combo Test|
|Study Start Date :||November 2010|
|Estimated Primary Completion Date :||May 2012|
|Estimated Study Completion Date :||July 2012|
This group of participants is primarily an out-patient population.
This group of participants is primarily an in-patient population.
Participants in this group are children 18 years or younger.
- Sensitivity and specificity for drug resistance detection [ Time Frame: approximately 12 months after the study is completed. ]Interim results may be assessed after the first year study.
- Sensitivity and Specificity of the Test for Influenza Diagnosis [ Time Frame: 12 months after the study is completed. ]Results may be assessed after the first year study.
Biospecimen Retention: Samples Without DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01506583
|United States, Alabama|
|University of Alabama at Birmingham||Recruiting|
|Birmingham, Alabama, United States, 35294|
|Contact: David Kimberlin, M.D. 205-934-5316 email@example.com|
|Contact: Dusty Giles, R.N. 205-934-7807 firstname.lastname@example.org|
|Principal Investigator: David Kimberlin, M.D.|
|United States, Illinois|
|Northwestern University Feinberg School of Medicine||Recruiting|
|Chicago, Illinois, United States, 61611|
|Contact: Mike Ison, M.S., M.D. 312-695-4186 email@example.com|
|Principal Investigator: Mike Ison, M.S., M.D.|
|United States, Maryland|
|University of Maryland School of Medicine||Completed|
|Baltimore, Maryland, United States, 21201|